The projections and other forward looking financial information found herein were not , when made , and are not , historical facts but are forward looking statements about the objectives , strategies , financial conditions , results of operations and businesses of Angiotech and its subsidiaries and are subject to important risks , uncertainties and assumptions . The forward looking statements and projections set out in this press release are , in the case of Angiotech 's Base Medical Products and Proprietary Medical Products businesses , based upon Angiotech 's reasonable estimates , assumptions and expectations about these businesses and the markets in which Angiotech operates at the time such information was prepared , or in the case of Angiotech 's Royalty business , are derived based upon certain publicly available information , including analyst reports and other sources , regarding expectations for certain products , in particular for sales of paclitaxel-eluting stents by certain of our partners from which we derive or expect to derive royalty revenue pursuant to intellectual property licensing agreements with those partners . In each case , such projections or forward looking statements are subject to significant business , economic , competitive and other uncertainties and contingencies ( including those set out under the heading " Risk Factors " contained in Angiotech 's Annual Report on Form 10-K for the year ended December 31 , 2009 , as updated in Angiotech 's most recent Form 10-Q and Management 's Discussion and Analysis for the six months ended June 30 , 2010 ) , which are beyond Angiotech 's or our partners ' control .